Test and Treat DC: Forecasting the Impact of a Comprehensive HIV Strategy in Washington DC
Open Access
- 15 August 2010
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 51 (4) , 392-400
- https://doi.org/10.1086/655130
Abstract
Background. The United States and international agencies have signaled their commitment to containing the human immunodeficiency virus (HIV) epidemicKeywords
This publication has 27 references indexed in Scilit:
- A Comparison of HIV Testing in the Emergency Department and Urgent CareThe Journal of Emergency Medicine, 2010
- Treatment Modification in Human Immunodeficiency Virus–Infected Individuals Starting Combination Antiretroviral Therapy Between 2005 and 2008JAMA Internal Medicine, 2010
- Improved Virological Outcomes in British Columbia Concomitant with Decreasing Incidence of HIV Type 1 Drug Resistance DetectionClinical Infectious Diseases, 2010
- Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 TherapyNew England Journal of Medicine, 2009
- High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO TrialClinical Infectious Diseases, 2009
- Preventing HIV transmission with antiretroviralsBulletin of the World Health Organization, 2009
- Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort studyBMJ, 2009
- Treatment for Primary HIV Infection: Projecting Outcomes of Immediate, Interrupted, or Delayed TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- The Cost Effectiveness of Combination Antiretroviral Therapy for HIV DiseaseNew England Journal of Medicine, 2001
- Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 InfectionAnnals of Internal Medicine, 1997